What is the Fiscal Year for Alumis?
Date: November 13, 2026
Alumis's current fiscal year starts on January 1, 2026, and ends on December 31, 2026. Their current quarter is Q4, which ends on December 31, 2026.
Current Fiscal Year Overview
Fiscal Year Start
January 1, 2026
Fiscal Year End
December 31, 2026
Current Quarter
Q4
Current Quarter End
December 31, 2026
Quarterly Breakdown
Q1
Jan 1, 2026 – Mar 31, 2026
Q2
Apr 1, 2026 – Jun 30, 2026
Q3
Jul 1, 2026 – Sep 30, 2026
Q4
Oct 1, 2026 – Dec 31, 2026
Company Information
Headquarters
South San Francisco, California
Industry
Biotechnology Research
Stock Symbol
ALMS
Website
https://alumis.comDescription
Alumis is a late-stage biopharmaceutical company developing next-generation targeted therapies for immune-mediated diseases designed to improve health outcomes – empowering people to reimagine their lives. What sets us apart is our precision approach to R&D. Our proprietary data analytics platform integrates genetic, genomic, proteomic, biological, and clinical insights to pinpoint the right targets, molecules, indications, patients, endpoints, and combinations – potentially accelerating development, enhancing therapy precision, and improving the probability of clinical success. Combined with our integrated approach to drug development, we believe this will drive smarter, faster progress against immune dysfunction.
Use Salesmotion for Account Data and Insights
Sales professionals can use Salesmotion to access comprehensive account intelligence and automate their research. Instantly get insights on companies like Alumis and uncover key business information that drives smarter conversations.
Book a demo today to strengthen your sales strategy with powerful data and actionable insights.